CAMSAP1 and neoplasm: In the CAMSAP1-MT group, GSVA scores of anti-tumor immunity, platinum-mediated apoptosis, and cell activity pathways were significantly higher than those in the CAMSAP1-WT group, and patients with high GSVA scores showed better prognosis than those with low GSVA scores (Figures 5A,B).